Reuters logo
BRIEF-Voyager Therapeutics reports positive results from ongoing trial for advanced parkinson’s disease
2017年9月6日 / 中午11点31分 / 14 天前

BRIEF-Voyager Therapeutics reports positive results from ongoing trial for advanced parkinson’s disease

Sept 6 (Reuters) - Voyager Therapeutics Inc

* Voyager Therapeutics announces positive results from ongoing Phase 1b trial of VY-AADC01 for advanced parkinson’s disease

* Pivotal phase 2-3 program on track to begin during late 2017 and to dose first patient during first half of 2018

* Robust and durable clinical effects achieved with substantial reductions in daily oral levodopa use and other parkinson’s medications

* Voyager Therapeutics Inc - one-time administrations of VY-AADC01 well-tolerated out to 24 months

* Voyager Therapeutics Inc - VY-AADC01 improved multiple measures of patients’ motor function and activities of daily living in cohorts 2 and 3 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below